BHCM
WVE icon

Brevan Howard Capital Management’s Wave Life Sciences WVE Stock Holding History

Brevan Howard Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
+60,884
New +$404K ﹤0.01% 1615

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Brevan Howard Capital Management's WVE Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 60,884 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #1615 among its holdings.

239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Brevan Howard Capital Management held 60,884 shares of Wave Life Sciences worth $354K as of Q2 2026.
  • Wave Life Sciences was a new Brevan Howard Capital Management position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1615 holding.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.